Drug firms fear ‘wasting’ money for a Brexit no-deal outcome

Drug firms fear 'wasting' money for a Brexit no-deal outcome Drugs companies in Wales have been distracted from creating new medicines as they are "wasting
Drug firms fear ‘wasting’ money for a Brexit no-deal outcome
Drugs companies in Wales have been distracted from creating new medicines as they are “wasting” time and money preparing for a no-deal Brexit, industry representatives have said. The UK government wants pharmaceutical firms to stockpile an extra six weeks’ worth of medicine in case of a no-deal. Talks with the EU are currently deadlocked over the Irish border. Those companies in Wales said “robust plans” were in place but money could be better spent on drugs. “The deadlock is a challenge for the industry,” said Dr Richard Greville, the Welsh branch director of the Association of the British Pharmaceutical Industry (ABPI). “Because of the global nature of the industry, the supply, the frictionless movement of goods is absolutely critical because some medicines are manufactured in the UK, some medicines are manufactured in the EU and some medicines are manufactured in the rest of the world. “But, basically, if you are a patient in Wales who needs access to that medicine no matter where it’s been manufactured you want the access to that medicine to be unrestricted.”

Leave a Reply

Your email address will not be published. Required fields are marked *